Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17106199 | 1.00 | CYP4F2 (0.36) | CYP4F2CYP4A11NPSR1KDM4EMAPT | |
| SCHEMBL17106422 | 0.87 | CYP4F2 (0.37) | CYP4F2CYP4A11KDM4EMAPT | |
| SCHEMBL17106392 | 0.87 | CYP4F2 (0.37) | CYP4F2CYP4A11KDM4EMAPT | |
| SCHEMBL17106336 | 0.82 | CYP4F2 (0.33) | CYP4F2CYP4A11 | |
| SCHEMBL17106338 | 0.82 | CYP4F2 (0.33) | CYP4F2CYP4A11 | |
| SCHEMBL17106381 | 0.80 | — | — | |
| SCHEMBL17106383 | 0.80 | — | — | |
| SCHEMBL17106388 | 0.80 | CYP4F2 (0.32) | CYP4F2CYP4A11 | |
| SCHEMBL17106387 | 0.80 | CYP4F2 (0.32) | CYP4F2CYP4A11 | |
| SCHEMBL5728819 | 0.79 | CYP4F2 (0.36) | CYP4F2CYP4A11NPSR1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3122847-A1 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2017-02-01 | — | — | EP | claimed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | claimed |
| WO-2015148743-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2015-10-01 | — | — | WO | claimed |
| US-20150275132-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2015-10-01 | — | — | US | claimed |
| EP-3521409-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2024-08-14 | — | — | EP | disclosed |
| EP-3122847-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2019-05-15 | — | — | EP | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| US-20150275132-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2015-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289593-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | CYP4F2 1702/4885CYP4A11 1787/4885NPSR1 546/4885 |
| US-20150275132-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | CYP4F2 1702/4885CYP4A11 1787/4885NPSR1 546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.